Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation

73Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

Abstract

Although triglyceride accumulation in the liver causes non-alcoholic fatty liver disease (NAFLD), hypercholesterolemia is also a main cause of NAFLD as well as atherosclerosis. However, NAFLD and atherosclerosis have not been investigated simultaneously in animal models fed a high-cholesterol diet. Moreover, it is unclear whether systemic inflammation can exacerbate both pathologies in the same model. Accordingly, this study investigated the effect of additional systemic inflammation on NAFLD and atherosclerosis induced by cholesterol overload in wild animals. New Zealand white rabbits were divided into 4 groups: groups I (control) and II received normal chow, and groups III and IV received a 1% cholesterol diet. To induce inflammation via toll-like receptor (TLR)-4 signaling, groups II and IV received subcutaneous injections of 0.5 mL of 1% carrageenan every 3 weeks. After 3 months, total cholesterol markedly increased in groups III and IV, and the serum expressions of systemic inflammatory markers were elevated in the groups II-IV. Early NAFLD lesions (e.g., mild fatty changes in the liver with sporadic fibrosis) and atherosclerosis (e.g., intimal hyperplasia composed of foam cells) were observed in both the liver and aorta specimens from group III, and advanced lesions were observed in group IV. The expressions of inflammatory cellular receptors, TLR-2 and TLR-4, in the aorta gradually increased from group I to IV but were similar in the liver in groups II-IV. Cholesteryl ester (CE) levels were higher in group IV than in group III, although the difference was not significant. CE levels in the aorta were similar between groups III and IV. Systemic inflammation can simultaneously exacerbate existing early lesions due to cholesterol overload in both the liver and aorta of rabbits. However, the cellular response of inflammatory receptors and expression of cholesterol metabolites differ between these organs. © 2014 Kim et al.

References Powered by Scopus

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

8800Citations
N/AReaders
Get full text

Steatohepatitis: A tale of two 'Hits'?

3839Citations
N/AReaders
Get full text

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

2899Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases

77Citations
N/AReaders
Get full text

Apple polyphenols decrease atherosclerosis and hepatic steatosis in ApoE<sup>−/−</sup> mice through the ROS/MAPK/NF-κB Pathway

70Citations
N/AReaders
Get full text

Immune imbalances in non-alcoholic fatty liver disease: From general biomarkers and neutrophils to interleukin-17 axis activation and new therapeutic targets

69Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kim, E. J., Kim, B. H., Seo, H. S., Lee, Y. J., Kim, H. H., Son, H. H., & Choi, M. H. (2014). Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. PLoS ONE, 9(6). https://doi.org/10.1371/journal.pone.0097841

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 26

62%

Researcher 10

24%

Professor / Associate Prof. 3

7%

Lecturer / Post doc 3

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 25

45%

Agricultural and Biological Sciences 15

27%

Pharmacology, Toxicology and Pharmaceut... 10

18%

Biochemistry, Genetics and Molecular Bi... 6

11%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free